Existing investor Hikma Ventures returned for a series B round that came amidst increased demand for Lemonaid's remote healthcare services.
Lemonaid Health, the US-based operator of an online healthcare platform, has secured $33m in series B funding from investors including Hikma Ventures, the corporate venturing vehicle for pharmaceutical company Hikma.
Venture capital firm Olive Tree Ventures led the round, which also featured Artis Ventures, Correlation Ventures, Sierra Ventures and undisclosed others. It boosted the company’s overall funding to $53m.
Founded in 2014, Lemonaid runs an online service where users can access treatment for conditions like asthma, diabetes hypertension or mental…
